STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

PEDIATRIC BRAIN TUMOR FOUNDATION OF THE UNITED STATES INC: Form 990, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
PEDIATRIC BRAIN TUMOR FOUNDATION OF THE UNITED STATES INC (EIN 58-1966822)
Tax period
2020-10-01 to 2021-09-30
Filed
2022-06-02
IRS object ID
202221539349300312
Schema version
2020v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-06-02T08:25:43-05:00ReturnTs
Tax Period End2021-09-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN440160260PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1FORVIS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1500 RIDGEFIELD COURTAddressLine1Txt
CityASHEVILLECityNm
State AbbreviationNCStateAbbreviationCd
ZIP28806ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2020-10-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN581966822EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PEDIATRIC BRAIN TUMOR FOUNDATIONBusinessNameLine1Txt
Business Name Line2OF THE UNITED STATES INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlPEDIBusinessNameControlTxt
Phone8286656891PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line16065 ROSWELL ROAD NE STE 505AddressLine1Txt
CityATLANTACityNm
State AbbreviationGAStateAbbreviationCd
ZIP30328ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonANNE SUTTONPersonNm
Person TitleSECRETARYPersonTitleTxt
Phone8286656891PhoneNum
Signature2022-06-02SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstANNEPersonFirstNm
Person LastSUTTONPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonAMY BIBBYPreparerPersonNm
PTINP00445891PTIN
Phone8282542254PhoneNum
Preparation2022-06-02PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerCOURTNEY DAVIESPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line16065 ROSWELL ROAD NE STE 505AddressLine1Txt
CityATLANTACityNm
State AbbreviationGAStateAbbreviationCd
ZIP30328ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$6,017,204GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.CURETHEKIDS.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1992FormationYr
Legal Domicile StateGALegalDomicileStateCd
Activity Or MissionELIMINATE CHILDHOOD BRAIN TUMORS AND SUPPORT FAMILIES LIVING WITH THIS DEVASTATING DISEASE.ActivityOrMissionDesc
Voting Members Governing Body12VotingMembersGoverningBodyCnt
Voting Members Independent12VotingMembersIndependentCnt
Total Employee38TotalEmployeeCnt
Total Volunteers350TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$3,836,629PYContributionsGrantsAmt
CY Contributions Grants$6,015,457CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$14,534PYInvestmentIncomeAmt
CY Investment Income-$15,461CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$3,851,163PYTotalRevenueAmt
CY Total Revenue$5,999,996CYTotalRevenueAmt
PY Grants And Similar Paid$1,992,418PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$2,128,614CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$1,865,638PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$1,907,400CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$717,603CYTotalFundraisingExpenseAmt
PY Other Expenses$769,584PYOtherExpensesAmt
CY Other Expenses$1,231,795CYOtherExpensesAmt
PY Total Expenses$4,627,640PYTotalExpensesAmt
CY Total Expenses$5,267,809CYTotalExpensesAmt
PY Revenues Less Expenses-$776,477PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$732,187CYRevenuesLessExpensesAmt
Total Assets BOY$5,248,201TotalAssetsBOYAmt
Total Assets EOY$6,277,731TotalAssetsEOYAmt
Total Liabilities BOY$549,498TotalLiabilitiesBOYAmt
Total Liabilities EOY$846,841TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$4,698,703NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$5,430,890NetAssetsOrFundBalancesEOYAmt
MissionVISION: A WORLD WITHOUT CHILDHOOD BRAIN TUMORS.MISSION: CARE. CURE. THRIVE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$3,966,715ExpenseAmt
Grant$2,128,614GrantAmt
Revenue$5,999,996RevenueAmt
DescSEE SCHEDULE ODesc
Total Program Service Expenses$3,966,715TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document25IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee38EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members12GoverningBodyVotingMembersCnt
Independent Voting Member12IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local ChaptersYes (1)LocalChaptersInd
Policies Reference ChaptersYes (1)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonGEOFF STILLPersonNm
Phone8284180814PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line16065 ROSWELL ROAD NE STE 505AddressLine1Txt
CityATLANTACityNm
State AbbreviationGAStateAbbreviationCd
ZIP30328ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (15 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
ANDREW AJ JANOWER
CHAIR1.00Yes (X)Yes (X)$0$0$0
KRISTIN YOUNG
VICE CHAIR1.00Yes (X)Yes (X)$0$0$0
ANNE SUTTON
SECRETARY1.00Yes (X)Yes (X)$0$0$0
JEFF GELFAND
TREASURER1.00Yes (X)Yes (X)$0$0$0
DOUG PORTER
CHAIRMAN EMERITUS1.00Yes (X)$0$0$0
CHUCK BODERMAN
DIRECTOR1.00Yes (X)$0$0$0
CHASE JONES
DIRECTOR1.00Yes (X)$0$0$0
LARRY LITTLE
DIRECTOR1.00Yes (X)$0$0$0
KARL MUELLER
DIRECTOR1.00Yes (X)$0$0$0
KEN MURPHY
DIRECTOR1.00Yes (X)$0$0$0
JOHN RAGNONI
DIRECTOR1.00Yes (X)$0$0$0
SUSIE ROSSICK
DIRECTOR1.00Yes (X)$0$0$0
JILL SCOGNAMIGLIO
DIRECTOR1.00Yes (X)$0$0$0
COURTNEY DAVIES
PRESIDENT/CEO50.00Yes (X)$275,380$0$0
GEOFF STILL
CFO50.00Yes (X)$132,887$0$13,892
FieldValueIRS element (for citing)
Total Reportable Comp From Org$408,267TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$13,892TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K2IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
All Other Contributions$6,015,457AllOtherContributionsAmt
Noncash Contributions$113,725NoncashContributionsAmt
Total Contributions$6,015,457TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,747TotalRevenueColumnAmt
Exclusion$1,747ExclusionAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Other$17,208OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Other-$17,208OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$17,208TotalRevenueColumnAmt
Exclusion-$17,208ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$5,999,996TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$15,461ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,668,820TotalAmt
Program Services$1,668,820ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$459,794TotalAmt
Program Services$459,794ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$422,159TotalAmt
Program Services$223,940ProgramServicesAmt
Management And General$143,143ManagementAndGeneralAmt
Fundraising$55,076FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,159,437TotalAmt
Program Services$790,259ProgramServicesAmt
Management And General$152,860ManagementAndGeneralAmt
Fundraising$216,318FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$39,738TotalAmt
Program Services$26,168ProgramServicesAmt
Management And General$8,335ManagementAndGeneralAmt
Fundraising$5,235FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$199,070TotalAmt
Program Services$105,213ProgramServicesAmt
Management And General$47,719ManagementAndGeneralAmt
Fundraising$46,138FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$86,996TotalAmt
Program Services$57,911ProgramServicesAmt
Management And General$16,422ManagementAndGeneralAmt
Fundraising$12,663FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$417,677TotalAmt
Program Services$219,044ProgramServicesAmt
Management And General$91,132ManagementAndGeneralAmt
Fundraising$107,501FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$43,678TotalAmt
Program Services$38,142ProgramServicesAmt
Fundraising$5,536FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$114,268TotalAmt
Program Services$63,243ProgramServicesAmt
Management And General$13,276ManagementAndGeneralAmt
Fundraising$37,749FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$15,410TotalAmt
Program Services$13,037ProgramServicesAmt
Management And General$2,373ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$224,945TotalAmt
Program Services$184,068ProgramServicesAmt
Management And General$36,411ManagementAndGeneralAmt
Fundraising$4,466FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$7,698TotalAmt
Program Services$6,014ProgramServicesAmt
Management And General$1,684ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$17,269TotalAmt
Program Services$15,719ProgramServicesAmt
Fundraising$1,550FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$15,797TotalAmt
Program Services$15,000ProgramServicesAmt
Management And General$797ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$17,158TotalAmt
Program Services$4,260ProgramServicesAmt
Management And General$12,898ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
FEES & LICENSES$340,758$68,906$46,856$224,996
MISCELLANEOUS$12,146$4,599$7,172$375
AUTO EXPENSE$4,062$2,578$1,484$0
REPAIRS & MAINTENANCE$929$0$929$0

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$5,267,809TotalAmt
Program Services$3,966,715ProgramServicesAmt
Management And General$583,491ManagementAndGeneralAmt
Fundraising$717,603FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$1,547,950BOYAmt
EOY$2,257,178EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$202,399BOYAmt
EOY$519,490EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$33,859BOYAmt
EOY$27,545EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$24,894LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$13,467LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$41,066BOYAmt
EOY$11,427EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$3,422,927BOYAmt
EOY$3,462,091EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,248,201BOYAmt
EOY$6,277,731EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$238,563BOYAmt
EOY$74,542EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$310,935BOYAmt
EOY$772,299EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$549,498BOYAmt
EOY$846,841EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,392,732BOYAmt
EOY$2,078,046EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,305,971BOYAmt
EOY$3,352,844EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,698,703BOYAmt
EOY$5,430,890EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,248,201BOYAmt
EOY$6,277,731EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$732,187ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,347,569CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,643,146CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,927,494CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,471,860CurrentTaxYearMinus1YearAmt
Current Tax Year$3,836,629CurrentTaxYearAmt
Total$32,226,698TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,347,569CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,643,146CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,927,494CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$6,471,860CurrentTaxYearMinus1YearAmt
Current Tax Year$3,836,629CurrentTaxYearAmt
Total$32,226,698TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$1,395,890SubstantialContributorsTotAmt
Public Support Total170$30,830,808PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$77,585CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$109,546CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$16,620CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$45,248CurrentTaxYearMinus1YearAmt
Current Tax Year$14,534CurrentTaxYearAmt
Total$263,533TotalAmt
FieldValueIRS element (for citing)
Total Support$32,490,231TotalSupportAmt
Public Support CY1700.94890PublicSupportCY170Pct
Public Support PY1700.94250PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A PART VIFormAndLineReferenceDesc
ExplanationTHE ORGANIZATION CHANGED THEIR YEAR END DATE TO 9/30.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,267,809FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$5,267,809FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$413,390FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$103,348FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$449,288CurrentYearMinus3Amt
Current Year Minus2$404,647CurrentYearMinus2Amt
Current Year Minus1$506,409CurrentYearMinus1Amt
Current Year$413,390CurrentYearAmt
Total$1,773,734TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$2,660,601LobbyingCeilingAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$112,322CurrentYearMinus3Amt
Current Year Minus2$101,162CurrentYearMinus2Amt
Current Year Minus1$126,602CurrentYearMinus1Amt
Current Year$103,348CurrentYearAmt
Total$443,434TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$665,151GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$816,243BeginningYearBalanceAmt
Contributions$225,703ContributionsAmt
End Year Balance$1,041,946EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,016,243BeginningYearBalanceAmt
Other Expenditures$200,000OtherExpendituresAmt
End Year Balance$816,243EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,016,243BeginningYearBalanceAmt
End Year Balance$1,016,243EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,716,243BeginningYearBalanceAmt
Other Expenditures$700,000OtherExpendituresAmt
End Year Balance$1,016,243EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$1,716,243BeginningYearBalanceAmt
End Year Balance$1,716,243EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY1.00000BoardDesignatedBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$24,894OtherCostOrOtherBasisAmt
Depreciation$13,467DepreciationAmt
Book Value$11,427BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$11,427TotalBookValueLandBuildingsAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$6,016,604TotalRevEtcAuditedFinclStmtAmt
Other Revenue$17,208OtherRevenueAmt
Revenue Not Reported$17,208RevenueNotReportedAmt
Revenue Subtotal$5,999,396RevenueSubtotalAmt
Investment Expenses Not Incld$600InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$600RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$5,999,996TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$5,284,417TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$17,208OtherExpensesIncludedAmt
Expenses Not Reported$17,208ExpensesNotReportedAmt
Expenses Subtotal$5,267,209ExpensesSubtotalAmt
Investment Expenses Not Incld2$600InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt$600ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$5,267,809TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:THE ENDOWMENT FUNDS ARE A BOARD DESIGNATED RESERVE FUND TO ASSURE THE FOUNDATION'S ABILITY TO RESPOND TO PROGRAM RELATED OPPORTUNITIES (BOTH RESEARCH AND FAMILY SUPPORT) THAT MAY BE BEYOND THE FUNDS AVAILABLE FROM NORMAL OPERATIONS.
PART X, LINE 2:THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF SEPTEMBER 30, 2021.
PART XI, LINE 2D - OTHER ADJUSTMENTS:LOSS ON SALE OF ASSETS 17,208.
PART XII, LINE 2D - OTHER ADJUSTMENTS:LOSS ON SALE OF ASSETS 17,208.

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (21 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVEBOSTONMA02215422263040501(C)(3)$190,750RESEARCH GRANTS
HEALTH RESEARCH ALLIANCE
PO BOX 13605RESEARCH TRIANGLE PARKNC27709680617198501(C)(3)$112,500RESEARCH GRANT
DUKE UNIVERSITY
PO BOX 602651CHARLOTTENC282602651560532129GOVT$150,000EARLY CAREER DEVELOPMENT
UNIVERSITY OF CINCINNATI
2830 VICTORY PARKWAYCINCINNATIOH45206311779020GOVT$150,000EARLY CAREER DEVELOPMENT
CHILDREN'S NATL MED CTRCHILDREN'S RSCH INST
111 MICHIGAN AVE NWWASHINGTONDC20010521640403501(C)(3)$28,593RESEARCH GRANT
WASHINGTON UNIVERSITY IN ST LOUIS
1 BROOKINGS DRST LOUISMO63130431519670GOVT$100,000RESEARCH GRANT
REGENTS OF UNIVERSITY OF MICHIGAN
G395 WOLVERINE TOWER LOW RISEANN ARBORMI481091279386006309GOVT$70,000RESEARCH GRANTS
REGENTS OF UNIV CA SAN FRANCISCO
1111 FRANKLIN ST 12TH FLOOROAKLANDCA94607942829914GOVT$100,000CLINICAL TRIAL
AMERICAN ASSOC FOR CANCER RESEARCH
615 CHESTNUT ST 17TH FLOORPHILADELPHIAPA191064404236251648501(C)(3)$90,000RESEARCH GRANT
SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA
1655 N COMMERCE PKWY SUITE 102WESTONFL33326453368209501(C)(3)$89,908OPPORTUNITY GRANT
CHILDREN'S HEALTHCARE OF ATLANTA
1600 TULLIE CIRCLEATLANTAGA30329582367819501(C)(3)$5,073VS. CANCER GRANT
AKRON CHILDREN'S HOSPITAL
214 W BOWERY STAKRONOH44308340714357501(C)(3)$5,013VS. CANCER GRANT
BRENNER CHILDREN'S HOSPITAL
MEDICAL CENTER BLVDWINSTONSALEMNC27157510190238501(C)(3)$18,569VS. CANCER GRANT
EAST TENNESSEE CHILDREN'S HOSPITAL
2018 W CLINCH AVEKNOXVILLETN37916626002604501(C)(3)$14,632VS. CANCER GRANT
HASBRO CHILDREN'S HOSPITAL
593 EDDY STPROVIDENCERI02903222538470501(C)(3)$5,177VS. CANCER GRANT
CHILDREN'S HOSPITAL OF PITTSBURGH
4401 PENN AVEPITTSBURGHPA15224251865744501(C)(3)$6,933VS. CANCER GRANT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVECINCINNATIOH45229310833936501(C)(3)$10,501VS. CANCER GRANT
OKLAHOMA CHILDREN'S HOSPITAL
1200 CHILDRENS AVEOKLAHOMA CITYOK73104731200262501(C)(3)$13,421VS. CANCER GRANT
SOCIETY OF NEUROONCOLOGY
PO BOX 273296HOUSTONTX772773296760499664501(C)(3)$8,000SYMPOSIUM EXPENSES
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
PO BOX 301439 UNIT 705HOUSTONTX77030746001118GOVT$7,862VS. CANCER GRANT
OSF HEALTHCARE CHILDREN'S HOSPITAL OF ILLINOIS
530 NE GLEN OAK AVEPEORIAIL61637370813229501(C)(3)$6,673VS. CANCER GRANT
FieldValueIRS element (for citing)
Total501c3 Org29Total501c3OrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxtCash GrantCashGrantAmt
DIRECT ASSISTANCE TO INDIVIDUALS$459,794
SCHOLARSHIPS

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationALL ANNUAL RESEARCH GRANTS ARE REVIEWED BY OUR RESEARCH ADVISORY NETWORK AND EVALUATED ON SEVERAL CRITERIA, INCLUDING SCIENTIFIC MERIT OF THE GRANT APPLICATION; SCIENTIFIC BACKGROUND OF THE RESEARCHERS; THE PEER REVIEWED RESEARCH PUBLICATIONS OF THE PRINCIPLE INVESTIGATORS APPLYING; THE SUPPORTING COLLABORATIVE RESEARCH ENVIRONMENT IN THE RESEARCH INSTITUTION; AND THE VIABILITY OF RESEARCH PROPOSED, AND FACILITIES AVAILABLE. EACH GRANT RECIPIENT IS REQUIRED TO SUBMIT PERIODIC UPDATES, AND A FINAL REPORT BEFORE THE FINAL GRANT PAYMENT IS MADE. EACH RESEARCH APPLICATION HAS TO HAVE A HYPOTHESIS DRIVEN RESEARCH PROPOSAL. EACH APPLICATION MUST HAVE A LIST OF SPECIFIC AIMS THAT ARE TO BE ACHIEVED OVER THE TIMELINE OF THE RESEARCH PROJECT. A TIME LINE IS REQUESTED FOR THE ACHIEVEMENT OF THE SPECIFIC AIMS. THE PROGRESS REPORTS REQUIRE THAT THE ACHIEVEMENT OF SPECIFIC AIMS BE DETAILED WITH A SCIENTIFIC DESCRIPTION OF THE MANNER IN WHICH THEY WERE ACHIEVED. IF AN EVENT HAS OCCURRED THAT ALTERS THE ACHIEVEMENT OF THE SPECIFIC AIMS WITHIN THE TIME LINE OF THE RESEARCH PLAN THE RESEARCHERS MUST GIVE A REASON THAT IT HAS NOT BEEN ACHIEVED AND A NO COST EXTENSION MAY BE REQUESTED AND A NEW TIMELINE IS ESTABLISHED BEFORE THE FINAL PROGRESS REPORT IS ISSUED. EACH GRANT ALLOWS FOR THE OPPORTUNITY OF A SITE VISIT BY THE PBTF AND THESE SITE VISITS ARE MADE BY THE DIRECTOR OF RESEARCH AS WELL AS THE SENIOR SCIENTIFIC RESEARCH ADVISOR, THE PBTF PRESIDENT AS WELL AS THE EXECUTIVE DIRECTOR. RESEARCHERS PRESENT THEIR RESEARCH RESULTS IN PERSON AND THE PBTF ASKS QUESTIONS ABOUT THE RESULTS. ALL GRANT APPLICATIONS AND RESEARCH PROJECTS HAVE THE SAME REQUIREMENTS ON GRANT APPROVAL AND REPORTING REGARDLESS OF THE LOCATION OF THE RESEARCHER AND HIS/HER INSTITUTION. THESE REPORTS ARE REVIEWED BY OUR DIRECTOR OF RESEARCH FUNDING AND OUR CONTRACTED SENIOR SCIENTIFIC RESEARCH ADVISOR. FINAL APPROVAL ON ALL GRANTS IS CONDITIONED ON BOARD OF DIRECTOR APPROVAL.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp

FieldValueIRS element (for citing)
PersonCOURTNEY DAVIESPersonNm
TitlePRESIDENT/CEOTitleTxt
Base Compensation Filing Org$275,380BaseCompensationFilingOrgAmt
Compensation Based On Rltd Orgs$0CompensationBasedOnRltdOrgsAmt
Bonus Filing Organization$0BonusFilingOrganizationAmount
Bonus Related Organizations$0BonusRelatedOrganizationsAmt
Other Compensation Filing Org$0OtherCompensationFilingOrgAmt
Other Compensation Rltd Orgs$0OtherCompensationRltdOrgsAmt
Deferred Compensation Flng Org$0DeferredCompensationFlngOrgAmt
Deferred Comp Rltd Orgs$0DeferredCompRltdOrgsAmt
Nontaxable Benefits Filing Org$0NontaxableBenefitsFilingOrgAmt
Nontaxable Benefits Rltd Orgs$0NontaxableBenefitsRltdOrgsAmt
Total Compensation Filing Org$275,380TotalCompensationFilingOrgAmt
Total Compensation Rltd Orgs$0TotalCompensationRltdOrgsAmt
Comp Report Prior990 Filing Org$0CompReportPrior990FilingOrgAmt
Comp Report Prior990 Rltd Orgs$0CompReportPrior990RltdOrgsAmt

Schedule M IRS990ScheduleM

Cars And Other Vehicles CarsAndOtherVehiclesGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution5ContributionCnt
Noncash Contributions Rpt F990$58,496NoncashContributionsRptF990Amt
Method Of Determining RevenuesFAIR MARKET VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (10 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART III LINE 4AWHILE COVID-19 CONTINUED TO INCREASE THE HEAVY TOLL A CHILD'S BRAIN TUMOR TAKES ON FAMILIES AND THREATENED PROGRESS TOWARDS A CURE, THE PEDIATRIC BRAIN TUMOR FOUNDATION LED THE CHILDHOOD BRAIN CANCER COMMUNITY IN CONTINUING TO PUSH FORWARD RESEARCH PROJECTS THAT ARE ACCELERATING THE DISCOVERY OF TARGETED THERAPIES, FAMILY SUPPORT PROGRAMS THAT ARE LESSENING THE EMOTIONAL, ECONOMIC, AND PHYSICAL IMPACT OF A CHILD'S BRAIN TUMOR DIAGNOSIS, AND ADVOCACY INITIATIVES THAT ARE RAISING AWARENESS ABOUT THE NEED TO IMPROVE OUTCOMES FOR PATIENT AND INCREASE FUNDING OF PEDIATRIC BRAIN TUMOR SCIENTIFIC RESEARCH. SUMMARY OF 2021 RESEARCH INVESTMENTS: PBTF'S MOMENTUM IN FUNDING CUTTING-EDGE PEDIATRIC BRAIN TUMOR RESEARCH IN 2021, DESPITE THE LINGERING IMPACT AND SLOWDOWNS AS A RESULT OF THE PANDEMIC, CONTINUED TO PICK UP SPEED. ALL EXISTING GRANTS CONTINUED IN THEIR PROGRESS AND NEW RESEARCH INITIATIVES WERE LAUNCHED. PBTF EMBRACED THE SCIENTIFIC COMMUNITY AND REINFORCED OUR COMMITMENT TO CONTINUING TO SUPPORT THEIR LIFE-CHANGING PROJECTS. THE PEDIATRIC BRAIN TUMOR FOUNDATION'S RESEARCH MISSION IS GUIDED BY OUR COMMITMENT TO MAXIMIZE THE NUMBER OF LIFE-CHANGING THERAPIES MOVING FROM DEVELOPMENT THROUGH COMMERCIALIZATION TO FIND TARGETED TREATMENTS FOR ALL KIDS BATTLING BRAIN TUMORS. THE FOLLOWING ARE PROJECTS THAT RECEIVED FUNDING FROM PBTF IN 2021 BASED ON THE SPECIFIC STRATEGIC INVESTMENT CATEGORY UNDER WHICH IT FALLS. BASIC SCIENCE AND CORE PROJECT RESOURCES: INVESTING IN NOVEL BASIC SCIENCE CONCEPTS AND CORE RESOURCES IN THE PEDIATRIC BRAIN TUMOR RESEARCH FIELD IS ESSENTIAL TO PBTF'S RESEARCH INVESTMENT STRATEGY. THERE ARE FEW FUNDING SOURCES AVAILABLE TO SCIENTISTS WHO ARE FOCUSED ON 'OUT OF THE BOX' IDEAS FOR CRACKING THE CODE ON ERADICATING PEDIATRIC BRAIN TUMORS; PBTF'S COMMITMENT TO BASIC SCIENCE AND CORE PROJECT RESOURCES PROVIDES THE FINANCIAL SUPPORT AND OPPORTUNITIES THAT RESEARCHERS NEED TO TEST PROMISING NEW HYPOTHESES THAT WILL LEAD TO THE NEXT TARGETED THERAPY. PBTF'S PARTNERSHIP WITH THE BRAIN TUMOR FUNDERS COLLABORATIVE ENTERED ITS THIRD YEAR IN SUPPORT OF THE IMMUNOTHERAPY RESEARCH INITIATIVE FOR THE PROJECT AT THE UNIVERSITY OF PITTSBURGH ENTITLED "INTERROGATING ANTI-TUMOR T-CELLS TO DEVELOP ADOPTIVE CELL TRANSFER (ACT) IMMUNOTHERAPY FOR PEDIATRIC HIGH-GRADE GLIOMAS" UNDER THE DIRECTION OF PRINCIPAL INVESTIGATOR DR. GARY KORNBASCH. $112,500 WAS PAID TO THE BTFC IN 2021 TO COVER THIS GRANT WITH A TOTAL INVESTMENT COMMITMENT OF $450,000 OVER THREE YEARS. HARNESSING THE PEDIATRIC HIGH-GRADE GLIOMA PATIENT'S IMMUNE SYSTEM TO ATTACK THE TUMOR IS A NOVEL IDEA IN THE TREATMENT OF ONE OF THE DEADLIEST TYPES OF BRAIN TUMORS. DRS. CASTRO AND LOWENSTEIN FROM THE UNIVERSITY OF MICHIGAN'S CHAD CARR PEDIATRIC BRAIN TUMOR CENTER ARE GRANT AWARDEES FOR A MULTI-YEAR PROJECT ENTITLED "NOVEL IMMUNE MEDIATED-GENE THERAPY FOR PEDIATRIC HIGH-GRADE GLIOMA" WITH AN AWARD TOTALING $669,533. AT THE INVESTIGATORS' REQUEST, THIS AWARD HAS BEEN EXTENDED THROUGH 2022 WITH AN UPCOMING FINAL PAYMENT OF $219,844. IN 2021, PBTF EMBARKED ON A NEW GRANT AWARD WITH THE UNIVERSITY OF MICHIGAN FOR A PROJECT ENTITLED "RAPID MOLECULAR TESTING OF HIGH GRADE GLIOMAS." IN THIS STUDY, THE INVESTIGATORS LEVERAGE LAMP AMPLIFICATION TECHNOLOGY AND HANDHELD ELECTRONIC SEQUENCING TO ANALYZE MOLECULAR ALTERATIONS, DELETIONS AND MUTATIONS IN BLOOD AND FLUID SAMPLES FROM PATIENTS BATTLING THE MOST AGGRESSIVE FORMS OF PEDIATRIC BRAIN TUMORS. THE AIM OF THE PROJECT IS TO DEVELOP A TECHNIQUE FOR A MORE RAPID DIAGNOSIS OF TUMORS IN ORDER FOR CLINICIANS TO MORE ACCURATELY PRESCRIBE TARGETED TREATMENTS FOR THE SPECIFIC ANOMALIES THAT ARE IDENTIFIED BEFORE THE TUMOR MUTATES INTO A DIFFERENT FORM. THIS IS A ONE-YEAR AWARD IN THE AMOUNT OF $70,000. PEDIATRIC DRUG DOSING IS AN UNDERSTUDIED AREA AS MOST CLINICAL TRIALS DETERMINE DRUG DOSING RECOMMENDATIONS FOR PHASE I TRIALS IN KIDS BASED ON ADULT STANDARDS. IN ORDER TO DEVELOP STANDARDS FOR MORE EFFECTIVE DRUG DOSING IN KIDS, PBTF FUNDED A RESEARCH PROJECT ENTITLED "FUNCTIONAL ENGAGEMENT AND EFFECT OF RAF-TARGETED THERAPIES IN GLIOMAS" IN PARTNERSHIP WITH THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. THE PRINCIPAL INVESTIGATOR FOR THE AWARD IS DR. KARISA SCHRECK AT JOHNS HOPKINS MEDICAL CENTER. THE TOTAL AWARD IS $200,000 OVER TWO YEARS. THE FINAL PAYMENT OF $90,000 WAS DISTRIBUTED IN 2021. IN 2021, A FINAL PAYMENT IN THE AMOUNT OF $66,000 WAS DELIVERED TO THE DANA FARBER CANCER INSTITUTE IN SUPPORT OF A TWO-YEAR CORE RESOURCE COMMITMENT TO SUPPORT THE HIRING OF A CLINICAL RESEARCH ASSISTANT (TOTAL AWARD $132,000). THIS INDIVIDUAL IS RESPONSIBLE FOR TUMOR TISSUE COLLECTION BY OBTAINING PARENTS' CONSENT O PRIOR TO SURGERY AND SHEPHERDING TISSUE HARVESTING DURING SURGERIES AND BIOPSIES. WITH AN INCREASE IN VIABLE TISSUE SAMPLES, SCIENTIFIC RESEARCH IS FUELED WITH MATERIAL TO TEST NEW HYPOTHESES AND POTENTIAL TREATMENT OPTIONS. THE MULTI-INSTITUTIONAL GRANT ENTITLED "OPTIMIZING OUTCOMES FOR PLGG PATIENTS" AWARDED FUNDS TO TWO OF THE THREE INSTITUTIONS ENGAGED IN THIS PROJECT. CHILDREN'S NATIONAL MEDICAL CENTER RECEIVED $28,593 AND CHILDREN'S HOSPITAL OF ATLANTA RECEIVED $8,210 AS THE PROJECT ENTERED THE SECOND YEAR OF PRODUCTIVITY. THE PURPOSE OF THIS PROJECT IS TO PERFORM A META ANALYSIS ON A COHORT OF PLGA SURVIVORS, ANALYZING THE OUTCOMES BASED ON QUALITY OF LIFE, TREATMENTS AND SPECIFIC MOLECULAR MUTATION. THE TOTAL GRANT AWARD FOR THIS PROJECT IS $364,141 OVER THREE YEARS. WASHINGTON UNIVERSITY OF ST. LOUIS'S PROJECT ENTITLED "HUMAN IPSC PLGA MODELS FOR THERAPEUTIC DRUG DISCOVERY AND EVALUATION" RECEIVED A SECOND YEAR OF FUNDING IN THE AMOUNT OF $100,000 IN 2021. THIS PROJECT (TOTAL OF 3 YEARS) IS WORKING TO CREATE A MOUSE MODEL FOR PLGA BRAIN TUMORS. WITHOUT MOUSE MODELS, SCIENTISTS ARE HAMPERED IN TESTING NEW THERAPIES AGAINST THE SPECIFIC TUMOR MUTATION WHICH IN TURN SLOWS THE PIPELINE OF THERAPY DEVELOPMENT. EARLY CAREER DEVELOPMENT AWARDEES FROM DUKE UNIVERSITY AND CHILDREN'S HOSPITAL OF CINCINNATI BOTH RECEIVED GRANT FUNDING IN 2021 TO SUPPORT PROJECTS ENTITLED "IDENTIFYING BRAINSTEM GLIOMA SUBTYPES THAT CAN BE RADIOSENSITIZED BY ATM INHIBITION AND "MAINTENANCE OF DIPG BLOOD-BRAIN BARRIER INTEGRITY BY ANGIOPOLETIN1" RESPECTIVELY. BOTH PROJECTS RECEIVED $150,000 FOR A TOTAL OF $300,000, WHICH IS PART OF A THREE YEAR GRANT AWARD. THESE PROJECTS WERE IN THEIR SECOND YEAR OF FUNDING IN 2021. GLOBAL TRAINING/EDUCATION: INTERNATIONAL COLLABORATION IN THE SCIENTIFIC COMMUNITY IS THE SINGLE MOST IMPORTANT INGREDIENT IN ACCELERATING RESEARCH PRODUCTIVITY. PBTF'S SUPPORT FOR ACADEMIC-DRIVEN INTERNATIONAL RESEARCH MEETINGS SPURS INNOVATION AND FACILITATES THE SHARING OF TIMELY RESEARCH DISCOVERIES ACROSS DISCIPLINES, SUB-SPECIALTIES, COUNTRIES, AND INSTITUTIONS. IN 2021, PBTF SPONSORED THE SOCIETY OF NEUROONCOLOGY'S PEDIATRIC BRAIN TUMOR BASIC AND TRANSLATIONAL SCIENCE CONFERENCE WHICH WAS CONVENED VIRTUALLY IN 2021. SCIENTIFIC MEETINGS SUCH AS THESE ARE A CRITICAL CORNERSTONE FOR THE RESEARCH COMMUNITY TO CONNECT AND SHARE REAL TIME DATA AND RESULTS, BUILD RELATIONSHIPS AND BREAKDOWN SILOS IN ORDER TO ACCELERATE THE PACE OF CUTTING-EDGE RESEARCH. THE SPONSORSHIP WAS $8,000 FOR THIS PREEMINENT MEETING. CLINICAL TRIALS: WHILE COVID DELAYED THE PACE OF MANY PROJECTS IN 2020 -- ESPECIALLY CLINICAL TRIALS, 2021 SAW A RESURGENCE OF TRIALS RE-OPENING FOR ENROLLMENT. THESE TRIALS CHALLENGE 'GOLD STANDARD' TREATMENTS AND EXPLORE NEW POSSIBILITIES FOR CHILDREN WHO HAVE RUN OUT OF OTHER EFFECTIVE TREATMENT OPTIONS. IN 2021, PBTF AWARDED CLINICAL TRIAL GRANTS TO: THE PEDIATRIC PACIFIC NEURO ONCOLOGY CONSORTIUM (PNOC) FOR A TRIAL ENTITLED "PNOC021-COMBINATORIAL CLINICAL TRIAL" WITH THE FUNDS BENEFITING THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. THIS IS A MULTI-YEAR AWARD TOTALING $300,000 WITH $100,000 DISBURSED IN 2021. THE DANA FARBER CANCER INSTITUTE (DFCI) FOR A TRIAL ENTITLED, "PHASE I/II TRIAL OF MEK162 IN LOW GRADE GLIOMA". THIS IS A MULTI-YEAR AWARD TOTALING $249,500 WITH $124,750 DISBURSED IN 2021. PROJECT OPEN DIPG IS A CONTINUATION OF A GRANT AWARDED IN 2019 FOR A CLINICAL TRIAL ENTITLED "PHASE 1 TRIAL OF MARIZOMIB ALONE AND IN COMBINATION WITH PANOBINOSTAT FOR CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA". THIS STUDY WAS PAUSED FOR ENROLLMENT IN 2020 AND EARLY 2021 DUE TO THE PANDEMIC; HOWEVER, IT HAS REOPENED AND IS MOVING FORWARD. THE GRANT AWARD WAS FOR $16,667 WHICH WAS FUNDED IN 2019, WITH THE GRANTEE REQUESTING A NO-COST EXTENSION THROUGH DECEMBER 2022.
PART III LINE 4A CONTINUEDFAMILY SUPPORT PROGRAM SERVICE ACCOMPLISHMENTS FROM COVID-19'S IMPACT ON PATIENTS' HEALTH AND FAMILIES' FINANCIAL STABILITY TO THE UNINTENDED CONSEQUENCES OF STRINGENT HOSPITAL SAFETY PROTOCOLS ON PATIENT CARE, THE PANDEMIC CONTINUED TO POSE SIGNIFICANT RISKS TO CHILDREN WITH BRAIN TUMORS AND THEIR FAMILIES IN 2021. BY CONTINUING TO IMPROVE THE ORGANIZATION'S APPROACH TO PATIENT FAMILY FOLLOW-UP, GROWING OUR COLLABORATIONS WITH HOSPITAL CARE PARTNERS, AND EXPANDING VIRTUAL OFFERINGS TO INCLUDE NEW SUPPORT GROUPS AND DIGITAL RESOURCES, PBTF INCREASED ITS ENGAGEMENT WITH FAMILIES BY 14.5% YEAR-OVER-YEAR AND INCREASED ITS REACH TO NEW FAMILIES BY 36.3% YEAR-OVER-YEAR. PBTF'S MONTHLY WEBINAR SERIES CONTINUED TO GROW IN 2021, WITH 10 WEBINARS COVERING THE FULL CONTINUUM OF CARE. INFORMED BY PATIENT FAMILY FEEDBACK, TOPICS FOCUSED ON NAVIGATING THE EMOTIONAL, INFORMATIONAL, AND LOGISTICAL CHALLENGES OF THE PEDIATRIC BRAIN TUMOR JOURNEY, INCLUDING EXPLORING TARGETED THERAPIES, UNDERSTANDING PEDIATRIC BRAIN TUMOR TYPES AND TREATMENTS, ENGAGING IN ADVOCACY, AND NAVIGATING SOCIAL SKILLS CHALLENGES. PATIENT FAMILIES RESPONDED POSITIVELY TO THIS YEAR'S TOPICS, WITH ATTENDANCE RATES INCREASING FROM 49% TO 55% YEAR-OVER-YEAR. AS PART OF PBTF'S COMMITMENT TO HELPING PATIENT FAMILIES NAVIGATE THE CHALLENGES OF COVID-19, PBTF'S JUNE WEBINAR WELCOMED THREE RENOWNED EXPERTS TO DISCUSS THE CURRENT STATE OF COVID-19 VACCINE STUDIES IN CHILDREN AND CONSIDERATIONS FOR VACCINATING CHILDREN IN TREATMENT AND POST-TREATMENT FOR A BRAIN TUMOR. PBTF'S SUPPORT OF FAMILIES THROUGH THE BUTTERFLY FUND DELIVERED $456,962.40 IN FINANCIAL RELIEF (A 3% INCREASE YEAR-OVER-YEAR), WITH $1258 PROVIDED TO EACH FAMILY ON AVERAGE. OUR BUTTERFLY FUND PARTNER HOSPITAL NETWORK ALSO EXPANDED TO PROVIDE AID TO PEDIATRIC BRAIN TUMOR PATIENTS IN TREATMENT AT C.S. MOTT CHILDREN'S HOSPITAL, INCREASING THE TOTAL NUMBER OF HOSPITAL PARTNERS TO 19 INSTITUTIONS NATIONWIDE. 52.3% OF BUTTERFLY FUND SUPPORT IN 2021 ASSISTED FAMILIES WITH HOUSING NEEDS, WITH OTHER KEY AREAS OF FINANCIAL ASSISTANCE INCLUDING SUPPORT FOR FUNERALS AND TRAVEL FOR TREATMENT. THE NATIONAL PEER TO PEER MENTORING PROGRAM CONTINUED TO GROW, WITH A 125% YEAR-OVER-YEAR INCREASE OF PATIENT FAMILIES MATCHED WITH TRAINED MENTORS WHO HAVE EXPERIENCED THE CHALLENGES OF THE CHILDHOOD BRAIN TUMOR JOURNEY. PBTF EXPANDED ITS SUPPORT OF THE HISPANIC AND LATINX PATIENT FAMILY COMMUNITY WITH THE INTRODUCTION OF THE STARFOLIO RESOURCE GUIDEBOOK IN SPANISH AND BROADENING OUR MONTHLY, CALIFORNIA-BASED SPANISH-LANGUAGE SUPPORT GROUPS TO REACH A NATIONWIDE PATIENT FAMILY AUDIENCE. ALTHOUGH PANDEMIC-RELATED CANCELLATIONS OF IN-PERSON SCHOOL AND SPORTS ACTIVITIES CONTINUED TO ADVERSELY IMPACT VS. CANCER FUNDRAISING EFFORTS THAT DIRECTLY FUND HOSPITAL GRANTS IN TEAMS' LOCAL COMMUNITIES, PBTF WAS ABLE TO CONTINUE ITS SUPPORT OF CRITICAL PEDIATRIC PATIENT SUPPORT PROGRAMS AT 49 HOSPITALS. PBTF'S VS. CANCER GRANTS REACHED 1203 PEDIATRIC BRAIN TUMOR FAMILIES IN 2021 AND SAFEGUARDED INITIATIVES SUCH AS: - UMASS MEMORIAL HEALTH'S MUSIC THERAPY THERAPY PROGRAM: UMASS MEMORIAL HEALTH HAS BEEN ABLE TO INCREASE THEIR MUSIC THERAPIST'S SCHEDULE IN THE LAST FOUR YEARS, SPECIFICALLY NOW PROVIDING SUPPORT TO THE HEMATOLOGY/ONCOLOGY CLINIC. EACH WEEK THE MUSIC THERAPIST WORKS 20 HOURS ON THE INPATIENT FLOOR AND 4 HOURS IN THE PEDIATRIC OUTPATIENT HEMATOLOGY/ONCOLOGY CLINIC. THE THERAPIST SEES PATIENTS INDIVIDUALLY AT THEIR BEDSIDE OR INFUSION CHAIR OR IN THE HOSPITAL'S PLAYROOM, TEACHING EVIDENCE-BASED METHODS TO RELAX AND MANAGE ANXIETY WITH MEANINGFUL, PATIENT-SELECTED ACTIVITIES. - MD ANDERSON'S AYA SCHOLARSHIPS: ADOLESCENTS AND YOUNG ADULTS HAVE EDUCATIONAL AND CAREER GOALS THAT ARE OFTEN DERAILED BY THEIR CANCER DIAGNOSIS/TREATMENT. EVEN AFTER TREATMENT IS OVER AND THEY WORK ON RECOVERING FROM THE PHYSICAL DAMAGE THAT HAS BEEN DONE, MANY PATIENTS/FAMILIES HAVE EXHAUSTED THEIR FINANCIAL SAVINGS TO PAY FOR CANCER TREATMENT. THE MD ANDERSON AYA SCHOLARSHIP HELPS PATIENTS PURSUE THEIR LIFE AND CAREER GOALS THROUGH VOCATIONAL SCHOOLS, COMMUNITY COLLEGE, FOUR-YEAR UNIVERSITIES, AND POST-GRADUATE PROGRAMS. - PHOENIX CHILDREN'S HARDSHIP FUND: VS. CANCER FUNDING PROVIDED BY PBTF TO PHOENIX CHILDREN'S HOSPITAL ADDRESSES THE FINANCIAL STRESS A FAMILY FACES WHEN RECEIVING TREATMENT. PHOENIX CHILDREN'S HISTORICALLY SERVES LOW-TO-MODERATE INCOME FAMILIES WITH 50% OR MORE OF THE FAMILIES LIVING AT OR BELOW POVERTY LEVEL. THEIR HARDSHIP FUND COVERS INCIDENTAL COSTS ASSOCIATED WITH HOSPITAL STAYS INCLUDING MEAL ASSISTANCE, GAS, LODGING AND TRANSPORTATION. FUNDING FROM PBTF'S 2021 VS. CANCER GRANT WILL SERVE APPROXIMATELY 84 FAMILIES. - DUKE'S PEDIATRIC NEUROPSYCHOLOGY PATIENT EVALUATION EFFORTS: THE LEARNING NEEDS OF PEDIATRIC BRAIN TUMOR PATIENTS ARE UNIQUE AND COMPLEX. DUKE'S PEDIATRIC NEUROPSYCHOLOGISTS PARTNER WITH MEMBERS OF THE SOCIAL WORK TEAM TO OUTLINE NECESSARY SUPPORT AT SCHOOL AND TO GUIDE ADVOCACY FOR ACCESSING THOSE SUPPORTS. THE RECOMMENDATIONS ARE BASED ON COGNITIVE SCREENING TOOLS AND OTHER COMPREHENSIVE EVALUATIONS FUNDED BY PBTF'S VS. CANCER GRANT. IT IS ANTICIPATED THAT APPROXIMATELY 30 PEDIATRIC BRAIN TUMOR PATIENTS WILL BENEFIT IN THE PROGRAM FROM THIS GRANT. PBTF LEADERSHIP ALSO SHARED FAMILY SUPPORT INSIGHTS WITH THE BROADER HEALTHCARE AND MEDICAL COMMUNITIES BY PRESENTING AND EXHIBITING AT THE ANNUAL MEETINGS FOR THE SOCIETY FOR NEUROONCOLOGY, ASSOCIATION OF PEDIATRIC ONCOLOGY SOCIAL WORKERS AND ASSOCIATION OF PEDIATRIC HEMATOLOGY ONCOLOGY NURSES. 2021 EXPANSION OF PBTF'S ADVOCACY LEADERSHIP PBTF'S MISSION OF CARE. CURE. THRIVE. IS ACHIEVED THROUGH FOCUSED PROGRAMS TO SUPPORT FAMILIES AS THEY NAVIGATE THE PEDIATRIC BRAIN TUMOR JOURNEY, AS WELL AS SUPPORT SCIENTISTS IN DISCOVERING NOVEL, MORE EFFECTIVE TREATMENTS FOR ALL TYPES OF BRAIN TUMORS IN KIDS. THESE EFFORTS ARE STRENGTHENED BY THE PBTF'S ADVOCACY INITIATIVES WHICH HELP SHINE THE SPOTLIGHT ON THIS PERNICIOUS DISEASE, THE #1 CAUSE OF CANCER DEATH IN KIDS. WHILE PBTF'S ADVOCACY SERVICES AND PROGRAMS ARE NON-GRANT BEARING, THEY DO HAVE A MAJOR IMPACT ON THE LEGISLATION THAT IS PASSED AND BRING ATTENTION TO THE DISEASE IN A BROADER CONTEXT THAN JUST THE CHILDHOOD CANCER COMMUNITY. IN ADDITION TO OUR DIRECT PATIENT ADVOCACY SUPPORT OF FAMILIES, PBTF CONTINUED TO SERVE AS THE LEADING CHAMPION FOR THE PEDIATRIC BRAIN TUMOR COMMUNITY THROUGH THE FOLLOWING INITIATIVES. IN 2021, THE PBTF WAS AN ACTIVE PARTICIPANT IN TWO LEGISLATIVE ADVOCACY DAYS ON CAPITOL HILL: - ACTION DAYS (APRIL 27, 2021): IN PARTNERSHIP WITH THE ALLIANCE FOR CHILDHOOD CANCER, ACTION DAYS RESULTED IN OVER 300 PEDIATRIC CANCER ADVOCATES FROM 39 STATES WHO MET WITH OVER 200 CONGRESSIONAL LEADERS TO AMPLIFY THE VOICES OF THE CHILDHOOD CANCER COMMUNITY. - HEAD TO THE HILL (MAY 4, 2021): IN PARTNERSHIP WITH THE NATIONAL BRAIN TUMOR SOCIETY, HEAD TO THE HILL RESULTED IN 410 BRAIN TUMOR ADVOCATES FROM 46 STATES TAKING PART IN 286 CONGRESSIONAL MEETINGS TO DO THE SAME. BOTH EFFORTS INCLUDED CONGRESSIONAL 'ASKS' WHICH WOULD RESULT IN CONTINUED FUNDING OF SPECIFIC PEDIATRIC CANCER AND PEDIATRIC BRAIN TUMOR RESEARCH INVESTMENTS THROUGH EXISTING LEGISLATION. THESE PEDIATRIC CANCER AND BRAIN CANCER ADVOCACY EFFORTS ARE DRIVING OUTCOMES FOR THE PATIENTS WE SERVE BY HELPING TO RAISE AWARENESS AND ENSURE THAT PEDIATRIC BRAIN TUMOR SCIENTIFIC RESEARCH IS PROPERLY FUNDED. PBTF IS PROUD OF THE ADVOCATES THAT ARE HELPING TO DRIVE BETTER OUTCOMES BY ENSURING THAT THE FUNDING FOR PEDIATRIC BRAIN TUMOR SCIENTIFIC RESEARCH IS AVAILABLE. FURTHERMORE, PBTF ESTABLISHED A LEADERSHIP POSITION IN THE COALITION AGAINST CHILDHOOD CANCER (CAC2) WITH THE INSTALLATION OF PBTF'S NATIONAL DIRECTOR OF RESEARCH AND ADVOCACY AS CAC2'S CURRENT BOARD CHAIR. THE MISSION OF THIS VOLUNTEER-LED, MEMBERSHIP-BASED ORGANIZATION IS TO FOSTER AND SUSTAIN GREATER LEVELS OF COORDINATED ACTION, INFORMATION EXCHANGE, EDUCATION AND LEARNING AND BROAD-BASED COLLABORATION BETWEEN KEY STAKEHOLDERS IN THE CHILDHOOD CANCER ARENA. THE OUTCOME OF WHICH IS TO DRAW GREATER ATTENTION AND RESOURCES TO THE DEADLIEST CHILDHOOD DISEASE IN ORDER TO CHANGE THE OUTCOME AND INCREASE RESOURCES FOR ALL CHILDREN UNDERGOING A CANCER DIAGNOSIS. A NUMBER OF CAC2'S PIVOTAL PROJECTS WERE DESIGNED AND IMPLEMENTED UNDER THE STEWARDSHIP OF THE NEW BOARD CHAIR INCLUDING THE #CANCELCHILDHOODCANCER CAMPAIGN; AN ENDORSEMENT LETTER SIGN-ON INITIATIVE; RESEARCHING, WRITING AND PRESENTING AT SIOP A NEW ETHICS DISCUSSION ENTITLED "DEVELOPING A WORKING PAPER TO CULTIVATE ETHICALLY SUSTAINABLE RELATIONSHIPS AMONG STAKEHOLDERS WHEN NONPROFITS FUND PEDIATRIC CANCER TRIALS; AND A NUMBER OF OTHER PROJECTS. ALL OF THESE EFFORTS SERVE TO DRAW FURTHER ATTENTION TO THIS DISEASE ON A LOCAL, NATIONAL AND GLOBAL SCALE.
PART III LINE 4A CONTINUEDIN 2021, PBTF ALSO SUPPORTED CUREFEST, THE NATION'S LARGEST FAMILY-LED, FAMILY-ATTENDED ADVOCACY EVENT IN WASHINGTON, DC ON SEPTEMBER 24TH WITH A $1700 GRANT. THIS EVENT DREW ATTENDEES FROM 50 STATES AND 68 COUNTRIES AND WAS LIVE STREAMED TO OVER 36,000 VIEWERS ACROSS THE GLOBE. THE OBJECTIVE OF THE EVENT IS TO DRAW ATTENTION TO THE PLIGHT OF PEDIATRIC CANCER PATIENTS AND THEIR FAMILIES AND ENGAGE IN PRODUCTIVE CONVERSATIONS AND RELATIONSHIP BUILDING EVENTS BETWEEN PATIENTS, FAMILIES, SURVIVORS, NON-PROFIT ORGANIZATIONS, LEGISLATORS, MEDIA, AND THE GENERAL PUBLIC. WHILE THIS EVENT TARGETS THE WIDER CHILDHOOD CANCER AUDIENCE, THE SUPPORT FROM PBTF WAS LEVERAGED IN PARTNERSHIP WITH THE DIPG COMMUNITY TO HOST THE INAUGURAL SUNRISE RESEARCH/CLINICIAN SESSION AND BREAKFAST. WITH OVER 210 ATTENDEES ATTENDING THIS NEWEST EVENT, THERE WAS GREAT ENERGY AROUND CHANGING OUTCOMES FOR CHILDREN BATTLING THE DEADLIEST OF BRAIN TUMORS.
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS MAY, BY RESOLUTION, DESIGNATE TWO (2) OR MORE DIRECTORS TO CONSTITUTE AN EXECUTIVE COMMITTEE, WHICH COMMITTEE, TO THE EXTENT PROVIDED IN SUCH RESOLUTION, SHALL HAVE AND MAY EXERCISE ALL OF THE AUTHORITY OF THE BOARD OF DIRECTORS IN THE MANAGEMENT OF THE CORPORATION EXCEPT AS OTHERWISE REQUIRED BY LAW. ALL MEMBERS OF THE EXECUTIVE COMMITTEE SHALL BE DIRECTORS OF THE CORPORATION. VACANCIES IN THE MEMBERSHIP OF THE COMMITTEE SHALL BE FILLED BY THE BOARD OF DIRECTORS AT ANY ANNUAL OR SPECIAL MEETING OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL KEEP REGULAR MINUTES OF ITS PROCEEDINGS AND REPORT THE SAME TO THE BOARD.
FORM 990, PART VI, SECTION B, LINE 11BTHE RETURN WAS PREPARED BY AN INDEPENDENT ACCOUNTANT WITH ASSISTANCE AND OVERSIGHT BY MANAGEMENT. THE CFO AND PRESIDENT REVIEWED THE RETURN WITH THE PREPARERS AT MULTIPLE STAGES OF COMPLETION. UPON RECEIVING A FINAL DRAFT, THE RETURN WAS PRESENTED AT A SCHEDULED BOARD MEETING. THE RETURN WAS PRESENTED TO THE FULL BOARD BY A MEMBER OF THE ACCOUNTING FIRM AND THE MANAGEMENT OF THE ORGANIZATION, AND A PERIOD OF TIME FOR QUESTIONS AND COMMENTS WAS ALLOWED.
FORM 990, PART VI, SECTION B, LINE 12CALL FINANCIAL TRANSACTIONS (BOTH REVENUE AND EXPENSE) ARE CONDUCTED WITH THE KNOWLEDGE AND/OR APPROVAL OF EITHER THE PRESIDENT/CEO OR THE CFO. THESE TRANSACTIONS ARE REVIEWED FOR ANY POTENTIAL CONFLICTS OF INTERESTS. ANY ISSUES ARE BROUGHT TO THE ATTENTION OF THE EXECUTIVE COMMITTEE.
FORM 990, PART VI, SECTION B, LINE 15THE BOARD'S EXECUTIVE COMMITTEE DETERMINES COMPENSATION AND BENEFITS FOR THE PRESIDENT/CEO AFTER REVIEWING THE MOST CURRENT GUIDESTAR NONPROFIT COMPENSATION REPORT, OTHER COMPARABLE DATA, SCOPE OF RESPONSIBILITY, SIZE OF ORGANIZATION, RESPONSIBILITY AND BUDGET TO DETERMINE THE REASONABLENESS OF THE SALARY.
FORM 990, PART VI, SECTION C, LINE 18RECENT FILINGS OF THE FORM 990 ARE AVAILABLE ONLINE AT CURETHEKIDS.ORG, GUIDESTAR, AND CHARITY NAVIGATOR.
FORM 990, PART VI, SECTION C, LINE 19THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE THROUGH INSPECTION AT THE ADMINISTRATIVE OFFICE IN FAIRVIEW, NC. ADDITIONALLY, THESE DOCUMENTS ARE MADE AVAILABLE TO ALL STATE GOVERNMENTS THAT REQUIRE ANNUAL FILING OF CHARITABLE ORGANIZATIONS.
FORM 990, PART XII, LINE 2C:THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.